{"title":"Diagnostic Accuracy of Serum Cystatin C for Early Detection of Kidney Damage in Patients with Type II Diabetes Mellitus: Bahawalpur, Pakistan","authors":"Iqra Sajid, Rabia Saeed, Arfa Goheer, Sameen Asghar, Sara Saqib, Fareeha Bashir","doi":"10.37185/lns.1.1.559","DOIUrl":null,"url":null,"abstract":"Objective: To determine the diagnostic accuracy of serum Cystatin C for early detection of kidney damage taking albumin Creatinine Ratio as a reference standard among people of Bahawalpur having diabetes mellitus type 2.Study Design: A cross-sectional study.Place and Duration of Study: The Study was conducted at the Department of Pathology in collaboration with th th Kidney Center, Bahawalpur Victoria Hospital, Bahawalpur, Pakistan from 27 August 2021 to 26 February 2022.Methods: There was a total of 200 patients having diabetes mellitus type 2 with GFR between 60-90ml/min with an age range from 40-60 years were selected. Study participants with a history of steroid intake, hypothyroidism, chronic liver disease, AIDS, and hypertension were not included in the study. For assessment of diagnostic accuracy of Cystatin C to evaluate the renal damages in early stages, microalbuminuria was evaluated. As per the guidelines provided by the respective manufacturers, individuals exhibiting two albumin creatinine ratio (ACR) levels exceeding 30 mg/g were classified as having diabetic nephropathy (DN).Results: The overall sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of serum Cystatin C for the early detection of kidney damage, with albumin-to-creatinine ratio used as the reference standard among individuals with type 2 diabetes mellitus, were 90.98%, 78.21%, 86.72%, 84.72%, and 86.0%, respectively.Conclusion: The findings of this investigation indicate that serum cystatin C (CysC) exhibits a considerable level of diagnostic accuracy in the early detection of kidney damage among individuals with type 2 diabetes mellitus, utilizing the albumin-to-creatinine ratio as a reference standard.How to cite this: Sajid I, Saeed R, Goheer A, Asghar S, Saqib S, Bashir F. Diagnostic Accuracy of Serum Cystatin C for Early Detection of Kidney Damage in Patients with Type II Diabetes Mellitus: Bahawalpur, Pakistan. Life and Science. 2024; 5(1): 41-47. doi: http://doi.org/10.37185/LnS.1.1.559","PeriodicalId":516717,"journal":{"name":"Life and Science","volume":"50 3-4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life and Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37185/lns.1.1.559","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To determine the diagnostic accuracy of serum Cystatin C for early detection of kidney damage taking albumin Creatinine Ratio as a reference standard among people of Bahawalpur having diabetes mellitus type 2.Study Design: A cross-sectional study.Place and Duration of Study: The Study was conducted at the Department of Pathology in collaboration with th th Kidney Center, Bahawalpur Victoria Hospital, Bahawalpur, Pakistan from 27 August 2021 to 26 February 2022.Methods: There was a total of 200 patients having diabetes mellitus type 2 with GFR between 60-90ml/min with an age range from 40-60 years were selected. Study participants with a history of steroid intake, hypothyroidism, chronic liver disease, AIDS, and hypertension were not included in the study. For assessment of diagnostic accuracy of Cystatin C to evaluate the renal damages in early stages, microalbuminuria was evaluated. As per the guidelines provided by the respective manufacturers, individuals exhibiting two albumin creatinine ratio (ACR) levels exceeding 30 mg/g were classified as having diabetic nephropathy (DN).Results: The overall sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of serum Cystatin C for the early detection of kidney damage, with albumin-to-creatinine ratio used as the reference standard among individuals with type 2 diabetes mellitus, were 90.98%, 78.21%, 86.72%, 84.72%, and 86.0%, respectively.Conclusion: The findings of this investigation indicate that serum cystatin C (CysC) exhibits a considerable level of diagnostic accuracy in the early detection of kidney damage among individuals with type 2 diabetes mellitus, utilizing the albumin-to-creatinine ratio as a reference standard.How to cite this: Sajid I, Saeed R, Goheer A, Asghar S, Saqib S, Bashir F. Diagnostic Accuracy of Serum Cystatin C for Early Detection of Kidney Damage in Patients with Type II Diabetes Mellitus: Bahawalpur, Pakistan. Life and Science. 2024; 5(1): 41-47. doi: http://doi.org/10.37185/LnS.1.1.559
目的以白蛋白肌酐比值为参考标准,确定血清胱抑素 C 对早期检测巴哈瓦尔布尔 2 型糖尿病患者肾脏损伤的诊断准确性:横断面研究:研究地点和时间:研究于2021年8月27日至2022年2月26日在巴基斯坦巴哈瓦尔布尔维多利亚医院病理科与肾脏中心合作进行:方法:共选取了 200 名 GFR 在 60-90 毫升/分钟之间、年龄在 40-60 岁之间的 2 型糖尿病患者。有类固醇摄入史、甲状腺功能减退症、慢性肝病、艾滋病和高血压的患者不在研究范围内。为评估胱抑素 C 对早期肾损害的诊断准确性,对微量白蛋白尿进行了评估。根据各生产商提供的指南,两次白蛋白肌酐比值(ACR)超过 30 毫克/克的个体被归类为糖尿病肾病(DN):结果:以白蛋白与肌酐比值作为参考标准,血清胱抑素 C 早期检测 2 型糖尿病患者肾脏损害的总体敏感性、特异性、阳性预测值、阴性预测值和诊断准确性分别为 90.98%、78.21%、86.72%、84.72% 和 86.0%:本研究结果表明,以白蛋白-肌酐比值作为参考标准,血清胱抑素C(CysC)在早期检测2型糖尿病患者肾脏损伤方面具有相当高的诊断准确性:Sajid I, Saeed R, Goheer A, Asghar S, Saqib S, Bashir F. 《血清胱抑素 C 早期检测 II 型糖尿病患者肾损伤的诊断准确性》:巴基斯坦巴哈瓦尔布尔。生命与科学》。2024; 5(1):41-47. DOI: http://doi.org/10.37185/LnS.1.1.559